73 related articles for article (PubMed ID: 16465049)
1. Development of a local perivascular paclitaxel delivery system for hemodialysis vascular access dysfunction: polymer preparation and in vitro activity.
Melhem M; Kelly B; Zhang J; Kasting G; Li J; Davis H; Heffelfinger S; Desai P; Roy-Chaudhury P
Blood Purif; 2006; 24(3):289-98. PubMed ID: 16465049
[TBL] [Abstract][Full Text] [Related]
2. Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model.
Kelly B; Melhem M; Zhang J; Kasting G; Li J; Krishnamoorthy M; Heffelfinger S; Rudich S; Desai P; Roy-Chaudhury P
Nephrol Dial Transplant; 2006 Sep; 21(9):2425-31. PubMed ID: 16822794
[TBL] [Abstract][Full Text] [Related]
3. In vitro paclitaxel and radiation effects on the cell types responsible for vascular stenosis: a preliminary analysis.
Zhang J; Melhem M; Kassing W; Kelly B; Wang Y; Krishnamoorthy M; Heffelfinger S; Desai P; Roy-Chaudhury P
Blood Purif; 2007; 25(2):155-60. PubMed ID: 17179736
[TBL] [Abstract][Full Text] [Related]
4. Novel therapies for hemodialysis vascular access dysfunction: fact or fiction!
Roy-Chaudhury P; Kelly BS; Melhem M; Zhang J; Li J; Desai P; Munda R; Heffelfinger SC
Blood Purif; 2005; 23(1):29-35. PubMed ID: 15627734
[TBL] [Abstract][Full Text] [Related]
5. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts.
Lim HJ; Nam HY; Lee BH; Kim DJ; Ko JY; Park JS
Biotechnol Prog; 2007; 23(3):693-7. PubMed ID: 17465527
[TBL] [Abstract][Full Text] [Related]
6. Suppression of neointimal hyperplasia by sirolimus-eluting expanded polytetrafluoroethylene (ePTFE) haemodialysis grafts in comparison with paclitaxel-coated grafts.
Baek I; Bai CZ; Hwang J; Park J; Park JS; Kim DJ
Nephrol Dial Transplant; 2012 May; 27(5):1997-2004. PubMed ID: 22058173
[TBL] [Abstract][Full Text] [Related]
7. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint.
Roy-Chaudhury P; Sukhatme VP; Cheung AK
J Am Soc Nephrol; 2006 Apr; 17(4):1112-27. PubMed ID: 16565259
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis.
Lee BH; Nam HY; Kwon T; Kim SJ; Kwon GY; Jeon HJ; Lim HJ; Lee WK; Park JS; Ko JY; Kim DJ
Nephrol Dial Transplant; 2006 Sep; 21(9):2432-8. PubMed ID: 16554328
[TBL] [Abstract][Full Text] [Related]
9. Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis.
Kelly BS; Heffelfinger SC; Whiting JF; Miller MA; Reaves A; Armstrong J; Narayana A; Roy-Chaudhury P
Kidney Int; 2002 Dec; 62(6):2272-80. PubMed ID: 12427156
[TBL] [Abstract][Full Text] [Related]
10. Hemodialysis vascular access dysfunction from basic biology to clinical intervention.
Roy-Chaudhury P; Kelly BS; Narayana A; Desai P; Melhem M; Munda R; Duncan H; Heffelfinger SC
Adv Ren Replace Ther; 2002 Apr; 9(2):74-84. PubMed ID: 12085383
[TBL] [Abstract][Full Text] [Related]
11. Vascular access in hemodialysis: issues, management, and emerging concepts.
Roy-Chaudhury P; Kelly BS; Melhem M; Zhang J; Li J; Desai P; Munda R; Heffelfinger SC
Cardiol Clin; 2005 Aug; 23(3):249-73. PubMed ID: 16084276
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel.
Masaki T; Rathi R; Zentner G; Leypoldt JK; Mohammad SF; Burns GL; Li L; Zhuplatov S; Chirananthavat T; Kim SJ; Kern S; Holman J; Kim SW; Cheung AK
Kidney Int; 2004 Nov; 66(5):2061-9. PubMed ID: 15496180
[TBL] [Abstract][Full Text] [Related]
13. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
[TBL] [Abstract][Full Text] [Related]
14. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients.
Fuster V; Charlton P; Boyd A
Hum Gene Ther; 2001 Nov; 12(16):2025-7. PubMed ID: 11727735
[TBL] [Abstract][Full Text] [Related]
15. Hemodialysis vascular access dysfunction: molecular mechanisms and treatment.
Mima A
Ther Apher Dial; 2012 Aug; 16(4):321-7. PubMed ID: 22817119
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs.
Luo Z; Akita GY; Date T; Treleaven C; Vincent KA; Woodcock D; Cheng SH; Gregory RJ; Jiang C
Circulation; 2005 Apr; 111(13):1679-84. PubMed ID: 15781730
[TBL] [Abstract][Full Text] [Related]
17. Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents.
Prasad CK; Resmi KR; Krishnan LK; Vaishnav R
J Biomater Appl; 2005 Apr; 19(4):271-86. PubMed ID: 15788425
[TBL] [Abstract][Full Text] [Related]
18. Vascular brachytherapy for hemodialysis vascular access dysfunction: exploring an unmet clinical need.
Roy-Chaudhury P; Duncan H; Barrett W; Elson H; Narayana A; Foley J; Misra S; Lynch PM; Zuckerman D
J Invasive Cardiol; 2003 Jan; 15 Suppl A():25A-30A. PubMed ID: 12668839
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy for dialysis access stenosis: unfulfilled promise or false expectations.
Ahmed S; Roy-Chaudhury P
Semin Dial; 2012 Jul; 25(4):464-9. PubMed ID: 22276964
[TBL] [Abstract][Full Text] [Related]
20. Endovascular dialysis interventions in the era of DOQI.
Greenberg JI; Suliman A; Angle N
Ann Vasc Surg; 2008 Sep; 22(5):657-62. PubMed ID: 18619775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
